Nucana Plc
Officers & Directors
Hugh Griffith, age 57, is Chief Executive Officer and Director. He co-founded the company in 2008 and has prior experience at MedAnnex Limited, Thirty Holdings Limited, EdixoMed Limited, Bioenvision, Inc., Quantanova Limited, Abbott Laboratories, and Warner-Lambert Company. He holds an M.B.A. from Cardiff Business School and a B.Sc. Honours in Biology from the University of Stirling. Jeffrey Bloss, M.D., age 69, has served as Chief Medical Officer since August 2021. He has over 20 years of oncology leadership experience at Eli Lilly, Genentech, Xencor, GSK, Astellas, and Aegerion, and was previously Chief Medical Officer at Tarveda Therapeutics and Aegerion Pharmaceuticals. He completed his medical training at Thomas Jefferson University Medical College and Juniata College. David Harrison, M.D., age 66, has been Head of Translational Medicine since December 2017. He holds professorships at the University of St. Andrews, University of Edinburgh, and University of Florida. He oversees ethics at Lothian NHS University Hospitals, has chaired UK government advisory committees, and has been involved with iCAIRD. He has served as director of Benenox Limited and non-executive director at ILC Therapeutics Limited. He is a Fellow of several Royal Colleges and trained at the University of Edinburgh. Ian Webster, age 45, is Interim Chief Financial Officer. Theresa Bruce, age 61, is Chief Operating Officer.
Nucana Plc currently has 12 employees.
|
